1. Inicio
  2. Proyectos y Estudios
  3. RETROSPECTIVE STUDY WITH CETUXIMAB PLUS PACLITAXEL AS FIRST LINE FOR RECURRENT AND/OR METASTATIC SCCHN (SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK): REAL WORLD.

RETROSPECTIVE STUDY WITH CETUXIMAB PLUS PACLITAXEL AS FIRST LINE FOR RECURRENT AND/OR METASTATIC SCCHN (SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK): REAL WORLD.

Datos básicos

Protocolo:
TTC-CET-2020-01
EUDRACT:
NCT:
Centro:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Año de incio:
2021
Año de finalización:
2021
ESTUDIO OBSERVACIONAL

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

GRUPO ESPAÑOL TRATAMIENTO TUMORES CABEZA Y CUELLO (TTCC)

Resultados del Ensayo Clínico

Sequential chemotherapy regimen of induction with panitumumab and paclitaxel followed by radiotherapy and panitumumab in patients with locally advanced head and neck cancer unfit for platinum derivatives. The phase II, PANTERA/TTCC-2010-06 study.

Martínez-Trufero J; (...); Mesía Nin R

Article. 10.1007/s12094-021-02567-z. 2021


Spanish cardiac catheterization and coronary intervention registry. 32nd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2022).

Jurado-Román A; (...); García de la Borbolla Fernández R

Article. 10.1016/j.rec.2023.07.012. 2023

  • Open Access.

Campos de Estudio

Compartir